This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xian, C. J. Search for Related Content PubMed PubMed Citation Articles by Xian, C. J.

Roles of Epidermal Growth Factor Family in the Regulation of Postnatal Somatic Growth

Department of Orthopaedic Surgery, Women’s and Children’s Hospital, North Adelaide 5006, Australia; and Disciplines of Paediatrics and Physiology, University of Adelaide, Adelaide 5005, Australia

Correspondence: Address all correspondence and requests for reprints to: A/Prof. Cory J. Xian, Ph.D., Department of Orthopaedic Surgery, Women’s and Children’s Hospital, 72 King William Road, North Adelaide, South Australia 5006, Australia. E-mail: cory.xian{at}adelaide.edu.au

Ligands of the epidermal growth factor receptor (EGF-R), known to be important for supporting tissue development particularly in the gut and brain, have also been implicated in regulating postnatal somatic growth. Although optimal levels of both milk-borne and endogenous EGF-R ligands are important for supporting postnatal somatic growth through regulating gastrointestinal growth and maturation, supraphysiological levels of EGF-R ligands can cause retarded and disproportionate growth and alter body composition because they can increase growth of epithelial tissues but decrease masses of muscle, fat, and bone. Apart from their indirect roles in influencing growth, possibly via regulating levels of IGF-I and IGF binding proteins, EGF-R ligands can regulate bone growth and modeling directly because they can enhance proliferation but suppress maturation of growth plate chondrocytes (for building a calcified cartilage scaffold for bone deposition), stimulate proliferation but inhibit differentiation of osteoblasts (for depositing bone matrix), and promote formation and function of osteoclasts (for resorption of calcified cartilage or bone). In addition, EGF-like ligands, particularly amphiregulin, can be strongly regulated by PTH, an important regulatory factor in bone modeling and remodeling. Finally, EGF-R ligands can regulate bone homeostasis by regulating a pool of progenitor cells in the bone marrow through promoting proliferation but suppressing differentiation of bone marrow mesenchymal stem cells.

This article has been cited by other articles:

				C. J. Mitchell, A. E. Nelson, M. J. Cowley, W. Kaplan, G. Stone, S. K. Sutton, A. Lau, C. M. Y. Lee, and K. K. Y. Ho Detection of Growth Hormone Doping by Gene Expression Profiling of Peripheral Blood J. Clin. Endocrinol. Metab., December 1, 2009; 94(12): 4703 - 4709. [Abstract] [Full Text] [PDF]

				H.-S. Byun, G.-S. Lee, B.-M. Lee, S.-H. Hyun, K.-C. Choi, and E.-B. Jeung Implantation-Related Expression of Epidermal Growth Factor Family Molecules and Their Regulation by Progesterone in the Pregnant Rat Reproductive Sciences, September 1, 2008; 15(7): 678 - 689. [Abstract] [PDF]

				S. Radom-Aizik, F. Zaldivar Jr., S.-Y. Leu, P. Galassetti, and D. M. Cooper Effects of 30 min of aerobic exercise on gene expression in human neutrophils J Appl Physiol, January 1, 2008; 104(1): 236 - 243. [Abstract] [Full Text] [PDF]